Drug Store News11h
Teva, Samsung Bioepis launch Soliris biosimilar
Epysqli is used to treat paroxysmal nocturnal hemoglobinuria, atypical hemolytic uremic syndrome and generalized myasthenia ...
Teva and Samsung Bioepis Announce Biosimilar EPYSQLI® (eculizumab-aagh) Injection Now Available in the United States
EPYSQLI ® (eculizumab-aagh) is now available to patients living with difficult-to-treat rare diseases like paroxysmal nocturnal hemoglobinuria, ...
Teva, Samsung Bioepis announce EPYSQLI availability in the U.S.
Teva Pharmaceuticals (TEVA) and Samsung Bioepis (SSNLF) announced the availability of EPYSQLI in the U.S. EPYSQLI is a biosimilar to Soliris ...
Contract Pharma11h
Teva and Samsung Bioepis Launch EPYSQLI in the U.S.
EPYSQLI is designed to treat gMG in adults who are anti-acetylcholine receptor antibody positive.
KLP Kapitalforvaltning AS Buys New Shares in Immunovant, Inc. (NASDAQ:IMVT)
KLP Kapitalforvaltning AS purchased a new position in shares of Immunovant, Inc. (NASDAQ:IMVT – Free Report) during the 4th quarter, Holdings Channel.com reports. The fund purchased 10,800 shares of ...